C-Peptide and Early Type 1 Diabetes Detection

Opinion
Video

A panelist discusses how C-peptide serves as a critical biomarker of endogenous insulin production, providing clinicians with valuable insights into remaining beta cell function that can guide personalized treatment approaches and help predict disease progression in patients with type 1 diabetes (T1D).

Video content above is prompted by the following:

  • C-peptide is increasingly recognized as a marker for beta cell function. Can you explain the role of C-peptide in practice?
  • How does early identification of T1D change the trajectory of disease management?
Recent Videos
2 experts in this video
2 experts in this video
1 expert in this video
2 experts are featured in this series.
2 experts in this video
2 experts in this video
1 expert in this video
Related Content
© 2025 MJH Life Sciences

All rights reserved.